In 1996 Hi-Tech Pharmaceuticals was one of the first companies in the United States to bring powerful Prohormone compounds to market such as Androstenedione, 1- and 4-Androstenediol, 19-NorAndrostenediol/dione, the now legendary 1-Testosterone… to name a few. However, in 2004 our legal team asked us to rethink what these products were and how the government may view them in the future.
Hi-Tech then spent the last decade working on novel plant androgens and anabolics, as well as DHEA based compounds. Fast forward to 2012 when Hi-Tech acquired ALRI, a company well known for their Prohormone innovation. A few years later Hi-Tech acquired another pioneering juggernaut in Sports One® — one of the earlier pioneers in the Prohormone industry. A short time later Hi-Tech acquired LG Sciences which has helped lead innovation in the Prohormone field to this day. With the acquisition of LG, the Hi-Tech family of brands inherited a broad base of Prohormone Intellectual property and patents.
On December 18, 2014, President Obama signed the Designer Anabolic Steroid Control Act of 2014 — DASCA for short. This leveled the playing field for Hi-Tech and its family of brands to utilize the past decades technologies we had developed to dominate the legal Prohormone market. We have exclusive licenses on patents such as 1-DHEA, 4-DHEA, 19-NorDHEA, and many more on the horizon. Through this, Hi-Tech has developed a novel, one-of-a-kind Cyclosome® Technology with a cost of more than $1 million to buy the necessary equipment, associated R&D, the ability to manufacture the finished tablets and the ability to bring these powerful hormones to market. With this costly barrier to entry, nobody is likely to have a strong Prohormone or testosterone booster/precursor program than Hi-Tech does in its stable of brands, nor manufacture in our world-class production facilities.